no-news
19.01.2017

EU experts presented methodologies to prepare the Drug Situation Country Overview in Turkmenistan

National partners from the Ministry of Health and Medical Industry and the Ministry of Internal Affairs participated in a workshop on the national drug situation and reporting. Experts from the Netherlands and Czech Republic presented evidence-based drug policies and provided an overview of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reporting system and key indicators.

National partners from the Ministry of Health and Medical Industry and the Ministry of Internal Affairs of Turkmenistan participated in a workshop on the national drug situation and reporting. Experts from the Netherlands and Czech Republic presented evidence-based drug policies and provided an overview of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reporting system and key indicators.

The European experts made a presentation on drug strategy and provided an overview on prevalence and patterns of drug use, health and social consequences, availability and coverage of prevention, and treatment and supply reduction (drug crimes, drug market, and drug seizures).

The workshop also focused on the preparation of the Drug Situation Country Overview by the Turkmen team of experts.

The Central Asia Drug Action Programme (CADAP 6) represents continuity of the EU policy and long-term engagement with Central Asian partners to help further strengthen their national strategies in drug and drug demand reduction policies. The programme is funded by the European Union and implemented by the Consortium from the Netherlands, Czech Republic, Poland and Germany, led by Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.

For more information, please contact:

Ms. Mehri Karakulova, CADAP 6 National Coordinator, by phone +993 69 051544, or e-mail: mehri.karakulova@giz.de

Back to news list